CAR-T免疫疗法：肿瘤靶向治疗的新策略(6)
[38] Xu XJ， Tang YM. Cytokine release syndrome in cancer immunotherapy with chimeric antigen receptor engineered T cells[J]. Cancer Lett， 2014， 343(2)： 172-178.
[39] Frey NV， Porter DL. Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia[J]. Hematology Am Soc Hematol Educ Program， 2016(1)： 567-572.
[40] Lee DW， Gardner R， Porter DL， et al. Current concepts in the diagnosis and management of cytokine release syndrome[J]. Blood， 2014， 124(2)： 188-195.
[41] Jones BS， Lamb LS， Goldman F， et al. Improving the safety of cell therapy products by suicide gene transfer[J]. Front Pharmacol， 2014， 5： 254.
[42] Maiti SN， Huls H， Singh H， et al. Sleeping beauty system to redirect T-cell specificity for human applications[J]. J Immunother， 2013， 36(2)： 112-123.
[43] Beatty GL， Haas AR， Maus MV， et al. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies[J]. Cancer Immunol Res， 2014， 2(2)： 112-120.
[44] Craddock JA， Lu A， Bear A， et al. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b[J]. J Immunother， 2010， 33(8)： 780-788. (李孟捷 邹秋玲 党尉)
[39] Frey NV， Porter DL. Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia[J]. Hematology Am Soc Hematol Educ Program， 2016(1)： 567-572.
[40] Lee DW， Gardner R， Porter DL， et al. Current concepts in the diagnosis and management of cytokine release syndrome[J]. Blood， 2014， 124(2)： 188-195.
[41] Jones BS， Lamb LS， Goldman F， et al. Improving the safety of cell therapy products by suicide gene transfer[J]. Front Pharmacol， 2014， 5： 254.
[42] Maiti SN， Huls H， Singh H， et al. Sleeping beauty system to redirect T-cell specificity for human applications[J]. J Immunother， 2013， 36(2)： 112-123.
[43] Beatty GL， Haas AR， Maus MV， et al. Mesothelin-specific chimeric antigen receptor mRNA-engineered T cells induce antitumor activity in solid malignancies[J]. Cancer Immunol Res， 2014， 2(2)： 112-120.
[44] Craddock JA， Lu A， Bear A， et al. Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b[J]. J Immunother， 2010， 33(8)： 780-788. (李孟捷 邹秋玲 党尉)